TESTOSTERONE PELLET 100 mg (with Cholesterol

FDA recall notice · announced May 14, 2025 · Bso

Class II FDA/FSIS Class II: use may cause temporary or medically reversible adverse health consequences.

The product

TESTOSTERONE PELLET 100 mg (with Cholesterol

Reason for recall

Presence of Particulate Matter: Glass particles were found in pellet vials.

Notes

Distribution: Nationwide in the USA
Lot/code information: Lot 20250102@6, exp 12/11/2025; Lot 20250130@4, exp 1/22/2026
Quantity: 2,762 vials
Status: Ongoing
Products in this recall event:
- TESTOSTERONE PELLET 200 mg BLUNT, 1 Pellet for Subcutaneous Use, This is a Compounded Drug, Not for Resale, RX or Office Use Only, Belmar Select Outsources, 12860 W. Cedar Drive #211, Lakewood, CO 802 (D-0416-2025)
- TESTOSTERONE PELLET 200 mg (with Cholesterol (D-0415-2025)
- TESTOSTERONE PELLET 200 mg BLUNT (with Cholesterol (D-0414-2025)
- TESTOSTERONE PELLET 200 mg (with Cholesterol (D-0413-2025)
- TESTOSTERONE PELLET 100 mg (with Cholesterol (D-0412-2025)

Source: U.S. Food and Drug Administration public recall data. This page reports official records and is not legal, medical, or repair advice.